Long-term outcome of therapist-guided internet-based cognitive behavioural therapy for body dysmorphic disorder (BDD-NET): a naturalistic 2-year follow-up after a randomised controlled trial.
body dysmorphic disorder
cognitive behaviour therapy
follow-up
long-term
obsessive-compulsive disorder
treatment
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
15 01 2019
15 01 2019
Historique:
entrez:
17
1
2019
pubmed:
17
1
2019
medline:
11
2
2020
Statut:
epublish
Résumé
Most patients with body dysmorphic disorder (BDD) do not receive evidence-based treatment. A randomised controlled trial (RCT) has found that a therapist-guided internet-based cognitive-behavioural therapy (CBT) programme for BDD (BDD-NET) can be delivered safely via the internet with significant improvements in BDD symptom severity in the short term. The purpose of this study was to evaluate if the therapeutic gains of BDD-NET are maintained 2 years after treatment. Academic medical centre. A naturalistic 2-year follow-up study of the 88 self-referred adult outpatients with a diagnosis of BDD that had received BDD-NET within the context of the RCT. The primary outcome was the BDD-Yale-Brown Obsessive-Compulsive Scale (YBOCS). Responder status was defined as a ≥30% reduction in symptoms. Remission was defined as no longer meeting Diagnostic and Statistical Manual of Mental Disorders 5th edition criteria for BDD. Secondary outcomes included measures of depression, global functioning and quality of life. The efficacy of BDD-NET was sustained long- term, with further improvements observed on the BDD-YBOCS during the follow-up period. At follow-up, 69% (95% CI 57% to 80%) were classified as responders and 56% (95% CI 43% to 69%) were in remission. Gains on depressive symptoms and global functioning were also sustained but not quality of life. A majority of participants reported that the main reason for seeking help for their BDD was the possibility to access the treatment from home. BDD-NET is an effective treatment for BDD, and the patients' gains are maintained in the long term. BDD-NET has the potential to increase access to CBT and may lower the threshold for BDD sufferers to seek help in the first place. NCT02010619.
Identifiants
pubmed: 30647044
pii: bmjopen-2018-024307
doi: 10.1136/bmjopen-2018-024307
pmc: PMC6340432
doi:
Banques de données
ClinicalTrials.gov
['NCT02010619']
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e024307Informations de copyright
© Author(s) (or their employer(s)) 2018. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
J Psychosom Res. 2011 Mar;70(3):286-93
pubmed: 21334500
Stat Med. 2011 Feb 20;30(4):377-99
pubmed: 21225900
Am J Psychiatry. 2006 May;163(5):907-12
pubmed: 16648334
Health Econ. 2006 Nov;15(11):1229-36
pubmed: 16625671
BMJ Open. 2014 Sep 25;4(9):e005923
pubmed: 25256187
Expert Rev Pharmacoecon Outcomes Res. 2012 Dec;12(6):745-64
pubmed: 23252357
Behav Ther. 2015 Nov;46(6):775-85
pubmed: 26520220
Psychol Med. 2018 Dec;48(16):2740-2747
pubmed: 29486813
Body Image. 2016 Sep;18:168-86
pubmed: 27498379
Acta Psychiatr Scand. 1994 Jan;89(1):21-8
pubmed: 8140903
Stat Med. 1991 Apr;10(4):585-98
pubmed: 2057657
Compr Psychiatry. 2013 Oct;54(7):893-903
pubmed: 23643073
BMJ Open. 2016 Apr 25;6(4):e009327
pubmed: 27113231
J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57
pubmed: 9881538
Behav Ther. 2017 Jul;48(4):462-473
pubmed: 28577583
BMJ. 2016 Feb 02;352:i241
pubmed: 26837684
Psychol Rev. 1977 Mar;84(2):191-215
pubmed: 847061
Am J Psychiatry. 2006 Jul;163(7):1280-2
pubmed: 16816236
Psychopharmacol Bull. 1997;33(1):17-22
pubmed: 9133747
Compr Psychiatry. 2005 Jul-Aug;46(4):254-60
pubmed: 16175755
BMC Med Res Methodol. 2010 Sep 03;10:79
pubmed: 20815883
J Clin Psychiatry. 2001 Jul;62(7):517-22
pubmed: 11488361
Behav Cogn Psychother. 2014 Jul;42(4):497-501
pubmed: 23829940
Behav Modif. 1999 Oct;23(4):620-9
pubmed: 10533443
BMC Med Res Methodol. 2012 Dec 05;12:184
pubmed: 23216665
BMJ. 2009 Jun 29;338:b2393
pubmed: 19564179
Clin Psychol Rev. 2016 Aug;48:43-51
pubmed: 27393916
Am J Psychiatry. 1997 Nov;154(11):1593-8
pubmed: 9356570
Behav Res Ther. 2009 Feb;47(2):119-27
pubmed: 19036354
Qual Life Res. 2005 Mar;14(2):441-51
pubmed: 15892433
Cochrane Database Syst Rev. 2009 Jan 21;(1):CD005332
pubmed: 19160252
Psychol Med. 2014 Oct;44(13):2877-87
pubmed: 25066102
Health Policy. 1990 Dec;16(3):199-208
pubmed: 10109801
Br J Psychiatry. 2013 Aug;203(2):146-51
pubmed: 23787060
Depress Anxiety. 2013 Sep;30(9):800-8
pubmed: 23596102
Psychol Med. 2013 May;43(5):1109-17
pubmed: 23171833
J Nerv Ment Dis. 2011 Apr;199(4):268-71
pubmed: 21451352